Stay updated on Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.

Latest updates to the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check37 days agoChange DetectedThe page has undergone significant content removal regarding a clinical study of SYNT001 for pemphigus, including detailed descriptions of the study's design, cohorts, and inclusion/exclusion criteria. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference17%
- Check44 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check87 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check102 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check109 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.